Cellular adaptation to cancer therapy along a resistance continuum
Gustavo S. França(Institute for Systems Biology), Itai Yanai(NYU Langone Health), Igor Dolgalev, Deborah A. Liberman, Marta Chiodin(New York University), Kwan Ho Tang(AstraZeneca (Netherlands)), Ayushi S. Patel(Icahn School of Medicine at Mount Sinai), Felicia Kuperwaser(Institute for Systems Biology), Jozef P. Bossowski(NYU Langone Health), Douglas A. Levine(New York University), Gal Avital, Timothée Lionnet(Albert Einstein College of Medicine), Maayan Baron, Dalia Barkley(Institute for Family Health), Thales Papagiannakopoulos(NYU Langone Health), Maayan Pour, Benjamin R. King(Institute for Systems Biology), Seli̇m Misirlioğlu(NYU Langone’s Laura and Isaac Perlmutter Cancer Center), Anjali Rao, Alicia Bjornberg(Moffitt Cancer Center), Andriy Marusyk(Moffitt Cancer Center)
Cited by 151
Related Papers
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Intra-tumour heterogeneity: a looking glass for cancer?
|Nature reviews. Cancer|2012|2k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Exploring tissue architecture using spatial transcriptomics
|Nature|2021|1.7k
Tumor heterogeneity: Causes and consequences
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2009|1.6k